• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Apricus Biosciences Inc

+ Add to Watchlist

NXEN:GR

0.842 EUR 0.007 0.84%

As of 11:22:54 ET on 12/17/2014.

Snapshot for Apricus Biosciences Inc (NXEN)

Open: 0.851 Day's Range: 0.822 - 0.854 Volume: 0
Previous Close: 0.835 52wk Range: 0.822 - 1.902 1-Yr Rtn: -38.41%

Stock Chart for NXEN

No chart data available.
  • NXEN:GR 0.850
  • 1D
  • 1M
  • 1Y
0.835
Interactive NXEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NXEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2430
Est. PEG Ratio -
Market Cap (M EUR) 37.33
Shares Outstanding (M) 44.33
30 Day Average Volume 867
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NXEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NXEN

Apricus Biosciences Inc. is a bio-technology company. The Company is seeking to monetize its existing product pipeline, including compounds from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer.

Richard W PascoeChief Executive OfficerBrian T DorseyChief Development Officer
Barbara TroupinChief Medical Officer
More Company Profile & Key Executives for NXEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil